Advertisement
Research Article

Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk

  • Jairam R. Lingappa mail,

    lingappa@uw.edu

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Pediatrics, University of Washington, Seattle, Washington, United States of America

    X
  • James P. Hughes,

    Affiliation: Department of Biostatistics, University of Washington, Seattle, Washington, United States of America

    X
  • Richard S. Wang,

    Affiliation: Department of Global Health, University of Washington, Seattle, Washington, United States of America

    X
  • Jared M. Baeten,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Washington, United States of America

    X
  • Connie Celum,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Washington, United States of America

    X
  • Glenda E. Gray,

    Affiliation: Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, Republic of South Africa

    X
  • Wendy S. Stevens,

    Affiliations: Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, Republic of South Africa, National Health Laboratory Service, University of the Witwatersrand, Johannesburg, Republic of South Africa

    X
  • Deborah Donnell,

    Affiliations: Statistical Center for HIV/AIDS, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

    X
  • Mary S. Campbell,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • Carey Farquhar,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Washington, United States of America

    X
  • M. Essex,

    Affiliation: Department of Immunology and Infectious Diseases, School of Public Health, Harvard University, Boston, Massachusetts, United States of America

    X
  • James I. Mullins,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Microbiology, University of Washington, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • Robert W. Coombs,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • Helen Rees,

    Affiliation: Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, Republic of South Africa

    X
  • Lawrence Corey,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • Anna Wald,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • for the Partners in Prevention HSV/HIV Transmission Study Team
  • Published: September 13, 2010
  • DOI: 10.1371/journal.pone.0012598

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.